American Academy of Allergy, Asthma & Immunology

"Not only has it shown efficacy in atopic dermatitis, but dupilumab also has shown efficacy in related atopic dermatitis conditions such as asthma and nasal polyps," said Akinlade.

Bola Akinlade, MD, MBA, Executive Director, Regeneron Pharmaceuticals, discussed the results of the dupilumab study presented at AAAAI 2017.

Jared Ditkowsky, MD, SUNY Downstate, explained the connotations surrounding the development of a potential vaccine for Chlamydia trachomatis (C. trachomatis), the infection causing chlamydia - one of the most common bacterial sexually transmitted infections in the United States.

The phase 3b MUSCA trial reported positive results for mepolizumab.

Jared Ditkowsky, MD candidate, SUNY Downstate explained that many of the problems surrounding a potential chlamydia vaccine are immunologic in nature.

Do emergency department physicians follow the asthma care guidelines?

Researchers analyze walnut immunotherapy outcomes at 142 weeks.

Jay Jin, MD, PhD, Mayo Clinic, shared the results from his team's case series surrounding unexpected bradycardia effect from epinephrine administration.

Females were less likely to be compliant, a contradiction to previous research.

Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), shared with MD Magazine what the main theme would be in his keynote address at the AAAAI 2017 meeting in Atlanta, GA: emerging and reemerging infections, a perpetual challenge.

Only a small percentage of people who think they have a penicillin allergy actually do.

How safe are anti-inflammatory medications for children?

Mark S. Forshag, MD, MHA, with GSK, shared some of his team's next steps in advancing asthma care specifically with trying to keep things simple for the patients and their physicians.

Mark S. Forshag, MD, MHA, GSK, spoke with MD Magazine at AAAAI 2017 in Atlanta, GA, about the importance of eosinophils in treating severe asthma.

A chlamydia vaccine would cut infection rates, but cost millions.

The SQ HDM SLIT-tablet is already approved in Europe. Is the US next?

The study was conducted in patients with grass pollen-induced allergic rhinoconjunctivitis.

Would carrying a rescue inhaler correlate with better asthma control? That's what Sima J. Patel, DO and her team sought to investigate.

Trial results on novel multi-dose powder inhaler were revealed at AAAAI 2017.

Luz Fonacier, MD, Winthrop University Hospital, detailed the process of looking at eczema and contact dermatitis in an allergist's practice.

In an ideal world, interventions would have a pilot study before RCT.

Which recommendations decrease asthma morbidity in children with asthma?

Matthew Perzanowski, PhD, discusses allergic asthma environmental factors.

Researchers are investigating whether microbial therapy can be an effective treatment for several skin and allergic conditions.

The gut microbiota modulates immune development and is an important component of neuroendocrine system. These interactions interfere with neuroendocrine development and, consequently, the patient's immune function.

Dietary amino acids are converted by the luminal microbiome in the gut to a bioactive compound, histamine, which binds to H2R and suppresses MAP kinase signaling and proinflammatory cytokines.

SLIT-tablets have a safety profile suitable for home treatment, as long as the first tablet intake is done under medical supervision. Long-term outcomes seem to differ between grass pollen SLIT-tablet products, and further studies are required.

Comparing safety and efficacy between sublingual immunotherapy and subcutaneous immunotherapy.

One of the hottest topics in medical science today is the role of the gut microbiome and its affect on various aspects of a person's health. A recent study looked at whether it can help predict the likelihood of a child having health issues linked to allergy and asthma.

For children going to school, their time in the classroom is a time of learning but also a time when germs can be spread on a wide scale basis. For asthma patients this can often mean several causes of their condition becoming worse without having done much to cause it.